Cargando…

Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells

Detalles Bibliográficos
Autores principales:	Wang, Xu, Hui, Renjie, Chen, Yun, Wang, Wentao, Chen, Yujiao, Gong, Xiaohai, Jin, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768923/ https://www.ncbi.nlm.nih.gov/pubmed/33381044 http://dx.doi.org/10.3389/fphar.2020.603491

Ejemplares similares

Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
por: Wang, Xu, et al.
Publicado: (2019)

Corrigendum: Furanodiene Induces Extrinsic and Intrinsic Apoptosis in Doxorubicin-Resistant MCF-7 Breast Cancer Cells via NF-κB-Independent Mechanism
por: Zhong, Zhang-Feng, et al.
Publicado: (2017)

A Novel Agent Enhances the Chemotherapeutic Efficacy of Doxorubicin in MCF-7 Breast Cancer Cells
por: Wang, Liang, et al.
Publicado: (2016)

A New Chalcone Derivative C49 Reverses Doxorubicin Resistance in MCF-7/DOX Cells by Inhibiting P-Glycoprotein Expression
por: Wang, Ting, et al.
Publicado: (2021)

Furanodiene Induces Extrinsic and Intrinsic Apoptosis in Doxorubicin-Resistant MCF-7 Breast Cancer Cells via NF-κB-Independent Mechanism
por: Zhong, Zhang-Feng, et al.
Publicado: (2017)

Discovery of IL-18 As a Novel Secreted Protein Contributing to Doxorubicin Resistance by Comparative Secretome Analysis of MCF-7 and MCF-7/Dox
por: Yao, Ling, et al.
Publicado: (2011)

Rational design of multifunctional micelles against doxorubicin-sensitive and doxorubicin-resistant MCF-7 human breast cancer cells
por: Hong, Wei, et al.
Publicado: (2017)

Rational Design of Multifunctional Micelles Against Doxorubicin-Sensitive and Doxorubicin-Resistant MCF-7 Human Breast Cancer Cells [Retraction]
Publicado: (2022)

Surface Stiffness Has No Impact on MCF-7 Sensitivity to Doxorubicin
por: Šimoliūnas, Egidijus, et al.
Publicado: (2023)

Knockdown of SALL4 inhibits the proliferation and reverses the resistance of MCF-7/ADR cells to doxorubicin hydrochloride
por: Chen, Yuan-Yuan, et al.
Publicado: (2016)

Role of autophagy and lysosomal drug sequestration in acquired resistance to doxorubicin in MCF-7 cells
por: Guo, Baoqing, et al.
Publicado: (2016)

Hypoxia-ameliorated photothermal manganese dioxide nanoplatform for reversing doxorubicin resistance
por: Chen, Zhenzhen, et al.
Publicado: (2023)

A Critical Dose of Doxorubicin Is Required to Alter the Gene Expression Profiles in MCF-7 Cells Acquiring Multidrug Resistance
por: Tsou, Shang-Hsun, et al.
Publicado: (2015)

Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells
por: Srdic-Rajic, Tatjana, et al.
Publicado: (2017)

Salinomycin enhances doxorubicin-induced cytotoxicity in multidrug resistant MCF-7/MDR human breast cancer cells via decreased efflux of doxorubicin
por: KIM, KWANG-YOUN, et al.
Publicado: (2015)

Metabolomic Identification of Anticancer Metabolites of Australian Propolis and Proteomic Elucidation of Its Synergistic Mechanisms with Doxorubicin in the MCF7 Cells
por: Alsherbiny, Muhammad A., et al.
Publicado: (2021)

Combined effect of papuamine and doxorubicin in human breast cancer MCF-7 cells
por: KANNO, SYU-ICHI, et al.
Publicado: (2014)

Cholesterol Dependent Uptake and Interaction of Doxorubicin in MCF-7 Breast Cancer Cells
por: Weber, Petra, et al.
Publicado: (2013)

The Cytotoxic and Antimigratory Activity of Brazilin-Doxorubicin on MCF-7/HER2 Cells
por: Jenie, Riris Istighfari, et al.
Publicado: (2018)

Synergistic Cytotoxicity of Renieramycin M and Doxorubicin in MCF-7 Breast Cancer Cells
por: Tun, Jortan O., et al.
Publicado: (2019)

Bibliometric and visual analysis of doxorubicin-induced cardiotoxicity
por: Lin, Xiaoxiao, et al.
Publicado: (2023)

Light-Responsive Micelles Loaded With Doxorubicin for Osteosarcoma Suppression
por: Chen, Jiayi, et al.
Publicado: (2021)

Comparative sphingolipidomic analysis reveals significant differences between doxorubicin-sensitive and -resistance MCF-7 cells
por: Shammout, Ola D. A., et al.
Publicado: (2021)

Identification of co-regulated genes associated with doxorubicin resistance in the MCF-7/ADR cancer cell line
por: Miri, Ali, et al.
Publicado: (2023)

Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer
por: Zhang, Hai-Bo, et al.
Publicado: (2023)

Berberine Maintains the Neutrophil N1 Phenotype to Reverse Cancer Cell Resistance to Doxorubicin
por: Zhang, Shuhui, et al.
Publicado: (2020)

Docetaxel and Doxorubicin Codelivery by Nanocarriers for Synergistic Treatment of Prostate Cancer
por: Li, Ke, et al.
Publicado: (2019)

Magnetic nanoparticles sensitize MCF-7 breast cancer cells to doxorubicin-induced apoptosis
por: Aljarrah, Khaled, et al.
Publicado: (2012)

Avoiding the Interference of Doxorubicin with MTT Measurements on the MCF-7 Breast Cancer Cell Line
por: Luis, Carla, et al.
Publicado: (2019)

Author Correction: Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells
por: Srdic-Rajic, Tatjana, et al.
Publicado: (2018)

Oxymatrine Synergistically Enhances Doxorubicin Anticancer Effects in Colorectal Cancer
por: Pan, Di, et al.
Publicado: (2021)

Inhibition of Akt phosphorylation attenuates resistance to TNF-α cytotoxic effects in MCF-7 cells, but not in their doxorubicin resistant derivatives
por: Ghandadi, Morteza, et al.
Publicado: (2016)

Dimethyl Fumarate Ameliorates Doxorubicin-Induced Cardiotoxicity By Activating the Nrf2 Pathway
por: Hu, Xiaoliang, et al.
Publicado: (2022)

Docosahexaenoic Acid, a Key Compound for Enhancing Sensitization to Drug in Doxorubicin-Resistant MCF-7 Cell Line
por: Crovella, Sergio, et al.
Publicado: (2023)

Doxorubicin resistance in breast cancer is mediated via the activation of FABP5/PPARγ and CaMKII signaling pathway
por: Chen, Nan-Nan, et al.
Publicado: (2023)

Doxorubicin Induces Endotheliotoxicity and Mitochondrial Dysfunction via ROS/eNOS/NO Pathway
por: He, Huan, et al.
Publicado: (2020)

Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells.
por: Schuurhuis, G. J., et al.
Publicado: (1993)

Long non-coding RNA H19 regulates proliferation and doxorubicin resistance in MCF-7 cells by targeting PARP1
por: Wang, Yu, et al.
Publicado: (2020)

Acrocomia aculeata associated with doxorubicin: cardioprotection and anticancer activity
por: Monteiro-Alfredo, Tamaeh, et al.
Publicado: (2023)

Synergistic combination of doxorubicin with hydralazine, and disulfiram against MCF-7 breast cancer cell line
por: Lafi, Zainab, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2ra43u3g7mf621d35p77g9dik7